AstraZeneca PLC Cash Flow-to-Debt Ratio
AstraZeneca PLC cash flow-to-debt ratio. AstraZeneca PLC (AZNN) has a Cash Flow-to-Debt Ratio of 0.04x as of December 2025, meaning its operating cash flow of MX$2.34 Billion could theoretically repay 0% of its total liabilities (MX$65.36 Billion) in one year. Check AstraZeneca PLC total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of AstraZeneca PLC (2014–2025)
Cash flow-to-debt ratio of AstraZeneca PLC from 2014 to 2025. Historical debt coverage capacity for AstraZeneca PLC across 12 annual periods. Check AstraZeneca PLC cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
AstraZeneca PLC Cash Flow-to-Debt Ratio by Year (2014–2025)
AstraZeneca PLC cash flow-to-debt ratio by year from 2014 to 2025. Year-by-year debt coverage analysis for AstraZeneca PLC. For the full cash flow conversion analysis, see AstraZeneca PLC (AZNN) cash conversion ratio.
| Year | CF-to-Debt Ratio | Operating CF (MXN) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.22x | MX$14.57 Billion | MX$65.36 Billion | ▲ +18.8% |
| 2024 | 0.19x | MX$11.86 Billion | MX$63.16 Billion | ▲ +12.3% |
| 2023 | 0.17x | MX$10.36 Billion | MX$61.95 Billion | ▲ +1.3% |
| 2022 | 0.17x | MX$9.81 Billion | MX$59.42 Billion | ▲ +82.9% |
| 2021 | 0.09x | MX$5.96 Billion | MX$66.08 Billion | ▼ -3.9% |
| 2020 | 0.09x | MX$4.80 Billion | MX$51.09 Billion | ▲ +48.0% |
| 2019 | 0.06x | MX$2.97 Billion | MX$46.78 Billion | ▲ +13.0% |
| 2018 | 0.06x | MX$2.62 Billion | MX$46.61 Billion | ▼ -26.7% |
| 2017 | 0.08x | MX$3.58 Billion | MX$46.71 Billion | ▼ -15.3% |
| 2016 | 0.09x | MX$4.14 Billion | MX$45.86 Billion | ▲ +13.0% |
| 2015 | 0.08x | MX$3.32 Billion | MX$41.55 Billion | ▼ -55.8% |
| 2014 | 0.18x | MX$7.06 Billion | MX$38.95 Billion | — |